Webcast

Dismantling Disparities in Primary Immunodeficiency Care: Building Blocks to Equity

Launch Date

01/25/2023

Credit Amount

1.00 Hours

Credit Expires

01/25/2024

Faculty

Antoine Azar, MD

Clinical Director, Division of Allergy and Clinical Immunology

Director, Adult Primary Immunodeficiency Center

Associate Professor of Medicine, Johns Hopkins School of Medicine, Baltimore, MD

Vivian Hernandez-Trujillo, MD

Founder, Allergy and Immunology Care Center of South Florida

Medical Director, Division of Allergy and Immunology, Nicklaus Children's Hospital

Clinical Professor of Pediatrics, Herbert Wertheim School of Medicine, Florida International University, Miami

Vivian Hernandez-Trujillo, MD

Vivian Hernandez-Trujillo, MD , is a specialist in Allergy and Immunology with 18 years of experience. She has board certifications in both Pediatrics and Allergy/Immunology and is a fellow of the American Academy of Pediatrics, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Dr. Hernandez-Trujillo received her medical degree from Albany Medical College in New York and completed a pediatric residency program at Miami Children’s Hospital. She completed her fellowship in Allergy and Immunology at the University of Tennessee, Memphis, St. Jude Children’s Research Hospital and Le Bonheur Children’s Medical Center.

Dr. Hernandez-Trujillo is a Clinical Professor at Florida International University Herbert Wertheim College of Medicine in Miami, Florida. She has served as the Medical Director for the Division of Allergy and Immunology at Nicklaus Children’s Hospital since 2008 and is also the Program Director of the Allergy/Immunology Fellowship training program. Dr. Hernandez-Trujillo is interested in education regarding pediatric allergic disease, and she lectures nationally and internationally on the topics of pediatric food allergy, anaphylaxis, and immunodeficiency. Dr Hernandez-Trujillo serves on numerous committees for national organizations, including executive committee member of the AAP Section of Allergy and Immunology, Allergy/Immunology representative to Council of Pediatric Subspecialties for the ACAAI, and the Immune Deficiency Foundation Medical Advisory Board.

Dr Hernandez-Trujillo has served as principal investigator or co-principal investigator on a number of clinical studies on primary immunodeficiency and has presented abstracts, posters, and lectures at meetings and conferences worldwide. She has published multiple articles in respected medical journals, co-edited the first two editions of the Board Review Textbook on Allergy/Immunology, and is author of the renowned UpToDate topic of Agammaglobulinemia. Her most recent research and work has been in the areas of healthcare disparities, particularly the impact on Hispanic/Latinx patients. She was active during the COVID-19 pandemic sharing information in Spanish through efforts with the Immune Deficiency Foundation, participating in podcasts and panels about healthcare disparities in patients with primary Immunodeficiency, and collaborating with the Allergy and Asthma Network on a Webinar series for Hispanic/Latinx patients and the impact of asthma.

Ilana Jacqueline, Patient Advocate

Author of "Surviving and Thriving with an Invisible Chronic Illness"

Statement of Need

In the United States, approximately 250,000 people have been diagnosed with a primary immunodeficiency (PI) disorder, and these patients have increased vulnerability to severe infections as well as lifelong impairment. Despite the severity of this disorder, however, there are significant disparities in diagnosis, treatment, and outcomes for patients diagnosed with PI who are from racial and ethnic underserved populations, as well as those of lower socioeconomic status.

This CME Outfitters Webcast will focus on addressing these persistent health disparities. Expert faculty will engage the audience in the development of improved skills in identifying the signs and symptoms of PI to reduce diagnostic delays, emphasize the importance of implementing consistent, guideline-directed treatment plans for all patients, and advise on the importance of effective patient-clinician communication and education.

Learning Objectives

At the end of this CME/CE activity, participants should be able to:

Identify signs and symptoms of PI to decrease diagnostic delays, especially in underserved populations.
Implement evidence-based treatment strategies to optimize PI management.
Educate and inform patients (and clinicians) about PI from the patient’s perspective.

Financial Support

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Target Audience

Physicians, nurse practitioners, PAs, infusion nurses, pharmacists, or other clinicians in primary care, as well as any clinician who manages or treats patients with PI.

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME)

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit ™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Pharmacists/Pharmacy Tech (ACPE)

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.

Family Physicians (AAFP)

The AAFP has reviewed the activity and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Prescribed credits. Term of Approval expires with the expiration date of the credit availability. Physicians should claim only the credit commensurate with the extent of their participation in the activity. AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.

PAs (AAPA)

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until the expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Patel reports the following financial relationships: Advisory Board: CSL Behring; Horizon Therapeutics; and Takeda Pharmaceuticals U.S.A., Inc. Consultant: Horizon Therapeutics. Grants: CSL Behring. Research Support: CSL Behring and Takeda Pharmaceuticals U.S.A., Inc.

Dr. Azar reports the following financial relationships: Advisory Board: Grifols and Opinose. Consultant: Argenx and Takeda Pharmaceuticals U.S.A., Inc. Grants and Research Support: Argenx; Grifols; and X4 Pharmaceuticals, Inc. Speakers Bureau: ADMA Biologics, Inc. and Grifols

Dr. Hernandez-Trujillo reports the following financial relationships: Advisory Board: Aimmune Therapeutics; Regeneron Pharmaceuticals Inc.; Sanofi; Takeda Pharmaceuticals U.S.A., Inc.; and US WorldMeds. Consultant: Amgen Inc.; CSL; Kaleo, Inc.; National Peanut Board; Pharming; and Takeda Pharmaceuticals U.S.A., Inc. Grants: Immune Deficiency Foundation. Speakers Bureau: CSL Behring and Takeda Pharmaceuticals U.S.A., Inc

Ms. Jacqueline reports no financial relationships to disclose.

The following CME Outfitters peer reviewer and staff have no financial relationships:

Elizabeth Naber, MSN, RN, CCRN-K, CNRN, TCRN (peer reviewer)
Morgan Stockberger, MD (planning committee)
Warren Beckman (planning committee)
Susan H. Yarbrough, CHCP (planning committee)
Sandra Caballero, PharmD (planning committee)
Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credits

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-23-011-H01-P